A £3.6 million refurbishment facility has been arranged to convert an existing commercial building in South Cambridgeshire into medical technology and office space, targeting demand in one of the UK’s established innovation markets.
The financing will support the redevelopment of approximately 20,000 sq ft of existing office and light-industrial space into modern office and med-tech accommodation. The scheme is located within Cambridge’s Southern Cluster, an area recognised for science, technology and innovation activity.
Refurbishment specifications
The planned works include over-cladding, upgraded thermal performance, fully electric services infrastructure and a target BREEAM ‘Excellent’ rating. The development aims to meet institutional-grade environmental and occupier requirements.
Justin Trowse, managing director for Mortimer Street Capital, which acted as funding adviser on the transaction, said: “The borrower presented a strong development plan focused on delivering office and med-tech space in a supply-constrained location, and London Credit understood and moved quickly to structure a competitive facility.”
Market context
The South Cambridgeshire market has maintained occupier demand for fitted commercial and research and development space, supported by proximity to science and biomedical campuses and transport connectivity. The area has received ongoing investment into the region’s innovation infrastructure.
While UK property sales have held steady despite economic uncertainty, specialist commercial refurbishment projects continue to attract lender interest in targeted sectors.
Marios Theophanous, credit manager at London Credit, said: “This case is a great example of the rise in mixed-use refurbishment projects, as investors look to improve existing assets, enhance income potential and bring underutilised space back into productive use.”
The facility was structured to provide flexibility during the early refurbishment phase while the developer secures a tenant and fitout specification. The transaction reflects continued lender appetite for repositioning opportunities in established commercial markets.